Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 Q2- Text added to 2016 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
accredited, acid, Addendum, AMPA, ascending, Aspire, clearance, complex, confidential, consent, decline, desire, discovered, dose, dosed, double, efficacy, epilepsy, exempt, family, found, importance, IND, localized, multiple, notice, partial, penalty, prevailing, propagation, recently, region, Regulation, reliance, resale, safety, secondarily, seizure, synaptic, TARP, therapy, thereunder, tolerability, Transmembrane, transmission, variety
Removed:
OpRA, weighted
Valuein 2016 Q2 filing- Value in 2016 Q3 filing
Original filings
Filing view